Dabigatran Reversal with Idarucizumab
N Engl J Med
.
2017 Oct 26;377(17):1691.
doi: 10.1056/NEJMc1711337.
Author
Marc Sorigue
1
Affiliation
1
Institut Català d’Oncologia, Badalona, Spain msorigue@iconcologia.net
PMID:
29082734
DOI:
10.1056/NEJMc1711337
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized*
Antithrombins
Dabigatran*
Humans
Substances
Antibodies, Monoclonal, Humanized
Antithrombins
idarucizumab
Dabigatran